✦ LIBER ✦

A randomized, double-blind, placebo-controlled phase II dose-finding study of the novel anti-muscarinic agent imidafenacin in Japanese patients with overactive bladder

✍ Scribed by Yukio Homma; Takuhiro Yamaguchi; Osamu Yamaguchi

Book ID: 108977779
Publisher: John Wiley and Sons
Year: 2008
Tongue: English
Weight: 129 KB
Volume: 15
Category: Article
ISSN: 0919-8172
DOI: 10.1111/j.1442-2042.2008.02104.x

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

A randomized, double-blind, placebo- and

A randomized, double-blind, placebo- and propiverine-controlled trial of the novel antimuscarinic agent imidafenacin in Japanese patients with overactive bladder

✍ Yukio Homma; Osamu Yamaguchi; Imidafenacin Study Group 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 167 KB

Randomized, double-blind, placebo- and p

Randomized, double-blind, placebo- and propiverine-controlled trial of the once-daily antimuscarinic agent solifenacin in Japanese patients with overactive bladder

✍ Osamu Yamaguchi; Eiji Marui; Hidehiro Kakizaki; Naoki Itoh; Takashi Yokota; Hiro 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 212 KB

Randomized, double-blind placebo- and to

Randomized, double-blind placebo- and tolterodine-controlled trial of the once-daily antimuscarinic agent solifenacin in patients with symptomatic overactive bladder

✍ C.R. Chapple; T. Rechberger; S. Al-Shukri; P. Meffan; K. Everaert; M. Huang; A. 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 190 KB

A phase II, randomized, double-blind, pl

A phase II, randomized, double-blind, placebo-controlled, dose-ranging study of belimumab in patients with active systemic lupus erythematosus

✍ Wallace, Daniel J. ;Stohl, William ;Furie, Richard A. ;Lisse, Jeffrey R. ;McKay, 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 372 KB 👁 2 views

## Abstract ## Objective To assess the safety, tolerability, biologic activity, and efficacy of belimumab in combination with standard of care therapy (SOC) in patients with active systemic lupus erythematosus (SLE). ## Methods Patients with a Safety of Estrogens in Lupus Erythematosus: National

Randomized double-blind placebo-controll

Randomized double-blind placebo-controlled multicenter evaluation of efficacy and dose finding of midodrine hydrochloride in women with mild to moderate stress urinary incontinence: a phase II study

✍ E. H. J. Weil; P. H. A. Eerdmans; G. A. Dijkman; K. Tamussino; J. Feyereisl; M. 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 756 KB

Ocrelizumab, a humanized anti-CD20 monoc

Ocrelizumab, a humanized anti-CD20 monoclonal antibody, in the treatment of patients with rheumatoid arthritis: A phase I/II randomized, blinded, placebo-controlled, dose-ranging study

✍ Mark C. Genovese; Jeffrey L. Kaine; Mitchell B. Lowenstein; José Del Giudice; An 📂 Article 📅 2008 🏛 John Wiley and Sons 🌐 English ⚖ 623 KB